Regenerative Medicine Insights

Stem cell research is transitioning from theory to clinical reality, with over 750 recent trials targeting conditions like osteoarthritis and heart disease. While global adoption grows, many Americans remain hesitant due to common misconceptions. Self-derive stem cell therapy is legal in the U.S. when minimally manipulated, poses low rejection risks, and avoids ethical issues by using adult cells rather than embryos. Compared to surgery, these treatments are minimally invasive with faster recovery times. Companies like Forever Labs now offer biobanking, allowing individuals to preserve their young cells for future longevity treatments.